Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by HUILAI ZHANG
The Combination of NVP-BKM120 With Trastuzumab or RAD001 Synergistically Inhibits the Growth of Breast Cancer Stem Cells in Vivo
Oncology Reports
Medicine
Cancer Research
Oncology
Related publications
Combination Treatment With Grb7 Peptide and Doxorubicin or Trastuzumab (Herceptin) Results in Cooperative Cell Growth Inhibition in Breast Cancer Cells
British Journal of Cancer
Cancer Research
Oncology
The Telomerase Inhibitor Imetelstat Alone, and in Combination With Trastuzumab, Decreases the Cancer Stem Cell Population and Self-Renewal of HER2+ Breast Cancer Cells
Breast Cancer Research and Treatment
Cancer Research
Oncology
The Combination of Ulinastatin and 5-Fluorouracil Synergistically Inhibits Hepatocellular Carcinoma Growth
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
The Anti-erbB3 Antibody MM-121/SAR256212 in Combination With Trastuzumab Exerts Potent Antitumor Activity Against Trastuzumab-Resistant Breast Cancer Cells
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Physical Intimacy of Breast Cancer Cells With Mesenchymal Stem Cells Elicits Trastuzumab Resistance Through SRC Activation
Scientific Reports
Multidisciplinary
Immunoselection of Breast and Ovarian Cancer Cells With Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells
Cancer Research
Cancer Research
Oncology
Oncolytic Adenovirus Armed With IL-24 Inhibits the Growth of Breast Cancer in Vitro and in Vivo
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Trastuzumab in Combination With AT-101 Induces Cytotoxicity and Apoptosis in Her2 Positive Breast Cancer Cells
Future Oncology
Medicine
Cancer Research
Oncology
Rapamycin by Itself and Additively in Combination With Carboplatin Inhibits the Growth of Ovarian Cancer Cells
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
